Filippo Caraci

Microfluidics as a Novel Tool for Biological and Toxicological Assays in Drug Discovery Processes: Focus on Microchip Electrophoresis

Giuseppe Caruso, Nicolò Musso, Margherita Grasso, 2020, Micromachines.

The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?

Andrea Caricasole, Georg C Terstappen, Filippo Caraci, 2003, Trends in pharmacological sciences.

Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.

Filippo Caraci, F. Nicoletti, F. Drago, 2010, European journal of pharmacology.

Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?

Giuseppe Battaglia, Filippo Caraci, A. Copani, 2012, Neurochemistry International.

Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers?

Filippo Caraci, Santo Di Nuovo, Sabrina Castellano, 2014, CNS & neurological disorders drug targets.

Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer’s Disease: Implications for the Treatment

Santo Di Nuovo, Filippo Caraci, Raffaele Ferri, 2013, Current genomics.

The nature of the cell cycle in neurons: focus on a "non-canonical" pathway of DNA replication causally related to death.

Filippo Caraci, F. Nicoletti, A. Copani, 2007, Biochimica et biophysica acta.

Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease

Jean-Luc Daval, Filippo Caraci, Raffaele Ferri, 2004, Neuroreport.

New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Filippo Caraci, S. Salomone, F. Drago, 2012, British journal of clinical pharmacology.